Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chawalit Ngernsombat

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Reports (Hoboken, N.J.)|July 17, 2020
CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell linePongphol Prattapong, Chawalit Ngernsombat, Sathid Aimjongjun, et al.
Frontiers in Oncology|February 13, 2023
Transcriptomic profiling revealed FZD10 as a novel biomarker for nasopharyngeal carcinoma recurrenceWarut Tulalamba, Chawalit Ngernsombat, Noppadol Larbcharoensub, et al.
Scientific Reports|September 1, 2017
CD2068 potentially mediates multidrug efflux in Clostridium difficileChawalit Ngernsombat, Suthasinee Sreesai, Phurt Harnvoravongchai, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
WNT8B as an Independent Prognostic Marker for Nasopharyngeal CarcinomaChawalit Ngernsombat, Pongphol Prattapong, Noppadol Larbcharoensub, et al.
EXCLI Journal|March 2, 2026
Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analysesChawalit Ngernsombat, Utid Suriya, Somsiri Udompaisarn, et al.
Cancers|September 3, 2020
Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma CarcinogenesisTimmy Richardo, Pongphol Prattapong, Chawalit Ngernsombat, et al.
Scientific Reports|December 29, 2024
Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validationChawalit Ngernsombat, Utid Suriya, Pongphol Prattapong, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Reports (Hoboken, N.J.)|July 17, 2020
CRISPR/Cas9-mediated double knockout of SRPK1 and SRPK2 in a nasopharyngeal carcinoma cell linePongphol Prattapong, Chawalit Ngernsombat, Sathid Aimjongjun, et al.
Frontiers in Oncology|February 13, 2023
Transcriptomic profiling revealed FZD10 as a novel biomarker for nasopharyngeal carcinoma recurrenceWarut Tulalamba, Chawalit Ngernsombat, Noppadol Larbcharoensub, et al.
Scientific Reports|September 1, 2017
CD2068 potentially mediates multidrug efflux in Clostridium difficileChawalit Ngernsombat, Suthasinee Sreesai, Phurt Harnvoravongchai, et al.
Current Oncology (Toronto, Ont.)|July 21, 2021
WNT8B as an Independent Prognostic Marker for Nasopharyngeal CarcinomaChawalit Ngernsombat, Pongphol Prattapong, Noppadol Larbcharoensub, et al.
EXCLI Journal|March 2, 2026
Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: Integrated in vitro and in silico analysesChawalit Ngernsombat, Utid Suriya, Somsiri Udompaisarn, et al.
Cancers|September 3, 2020
Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma CarcinogenesisTimmy Richardo, Pongphol Prattapong, Chawalit Ngernsombat, et al.
Scientific Reports|December 29, 2024
Repurposing FDA-approved drugs targeting FZD10 in nasopharyngeal carcinoma: insights from molecular dynamics simulations and experimental validationChawalit Ngernsombat, Utid Suriya, Pongphol Prattapong, et al.
Pageof 1